No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originated.

CD4 downregulation Cameroon HIV-1 Nef HIV-1 group M HLA-I downregulation

Journal

Frontiers in virology (Lausanne, Switzerland)
ISSN: 2673-818X
Titre abrégé: Front Virol
Pays: Switzerland
ID NLM: 9918334884106676

Informations de publication

Date de publication:
29 May 2024
Historique:
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: ppublish

Résumé

HIV-1 group M (HIV-1M) lineages downregulate HLA-I and CD4 expression via their Nef proteins. We hypothesized that these Nef functions may be partially responsible for the differences in prevalence of viruses from different lineages that co-circulate within an epidemic. Here, we characterized these two Nef activities in HIV-1M isolates from Cameroon, where multiple variants have been circulating since the pandemic's origin. Single HIV-1 Nef clones from 234 HIV-1-ART naïve individuals living in remote villages and two cosmopolitan cities of Cameroon, sampled between 2000 and 2013, were isolated from plasma HIV RNA and analyzed for their capacity to downregulate HLA-I and CD4 molecules. We found that, despite a large degree of within- and inter- lineage variation, the ability of Nef to downregulate HLA-I was similar across these different viruses. Moreover, Nef-mediated CD4 downregulation activity was also well conserved across the different lineages found in Cameroon. In addition, we observed a trend towards higher HLA-I downregulation activity of viruses circulating in the cosmopolitan cities versus the remote villages, whereas the CD4 downregulation activities were similar across the two settings. Furthermore, we noted a significant decline of HLA-I downregulation activity from 2000 to 2013, providing additional evidence supporting the attenuation of the global HIV-1M population over time. Finally, we identified 18 amino acids associated with differential HLA-I downregulation and 13 amino acids associated with differential CD4 downregulation within the dominant CRF02_AG lineage. Our lack of observation of HIV lineage-related differences in Nef-mediated HLA-I and CD4 downregulation function suggests that these activities do not substantively influence the prevalence of different HIV-1M lineages in Cameroon.

Identifiants

pubmed: 38883214
doi: 10.3389/fviro.2024.1379217
pmc: PMC7616105
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Nelson Sonela (N)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, Cameroon.
Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management (CIRCB), Yaoundé, Cameroon.
Department of Medicine, Weill Cornell Medical College, Cornell University, New York, NY, United States.

Jaclyn Mann (J)

HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.

Celestin Godwe (C)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, Cameroon.
Départment of Biochemistry, University of Douala, Douala, Cameroon.

Oumarou H Goni (OH)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, Cameroon.
Départment of Microbiology, Faculty of Sciences, University of Yaoundé 1, Yaoundé, Cameroon.

Mérime Tchakoute (M)

Programmes de Santé et développement au sein du Groupement de la Filière Bois du Cameroun, Yaoundé, Cameroon.

Nathalie Nkoue (N)

Programmes de Santé et développement au sein du Groupement de la Filière Bois du Cameroun, Yaoundé, Cameroon.

Tulio de Oliveira (T)

Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Mark A Brockman (MA)

Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.

Zabrina L Brumme (ZL)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.

Thumbi Ndung'u (T)

HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
Max Planck Institute for Infection Biology, Berlin, Germany.
Africa Health Research Institute (AHRI), Durban, South Africa.
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States.
Division of Infection and Immunity, University College London, London, United Kingdom.

Marcel Tongo (M)

Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, Cameroon.

Classifications MeSH